BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15378507)

  • 21. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
    Yeh KH; Cheng AL; Su IJ; Lin MT; Tien HF; Shen MC; Wang CH; Chen YC
    Anticancer Res; 1997; 17(3C):2269-72. PubMed ID: 9216700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell.
    Liang R; Todd D; Ho FC
    Hematol Oncol; 1996 Mar; 14(1):1-6. PubMed ID: 8613131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
    Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
    Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
    Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
    Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
    Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
    Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of proliferative activity of diffuse large cell lymphomas.
    Kossakowska AE; Huchcroft S; Boras V; Urbanski SJ
    Hematol Pathol; 1991; 5(3):101-7. PubMed ID: 1960133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease.
    Ahmed S; Kussick SJ; Siddiqui AK; Bhuiya TA; Khan A; Sarewitz S; Steinberg H; Sison CP; Rai KR
    Eur J Cancer; 2004 Jun; 40(9):1320-6. PubMed ID: 15177490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
    Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
    Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
    Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
    Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL).
    Callea V; Clò V; Morabito F; Baldini L; Stelitano C; Narni F; Avanzini P; Brugiatelli M; Silingardi V
    Haematologica; 1998 Nov; 83(11):993-7. PubMed ID: 9864919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).
    Mitterbauer-Hohendanner G; Mannhalter C; Winkler K; Mitterbauer M; Skrabs C; Chott A; Simonitsch-Klupp I; Gleiss A; Lechner K; Jaeger U
    Leukemia; 2004 Jun; 18(6):1102-7. PubMed ID: 15085149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.
    Muris JJ; Meijer CJ; Cillessen SA; Vos W; Kummer JA; Bladergroen BA; Bogman MJ; MacKenzie MA; Jiwa NM; Siegenbeek van Heukelom LH; Ossenkoppele GJ; Oudejans JJ
    Leukemia; 2004 Mar; 18(3):589-96. PubMed ID: 14712286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.
    López-Guillermo A; Cid J; Salar A; López A; Montalbán C; Castrillo JM; González M; Ribera JM; Brunet S; García-Conde J; Fernández de Sevilla A; Bosch F; Montserrat E
    Ann Oncol; 1998 Aug; 9(8):849-55. PubMed ID: 9789607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma.
    Nola M; Pavletic SZ; Weisenburger DD; Smith LM; Bast MA; Vose JM; Armitage JO
    Am J Hematol; 2004 Sep; 77(1):31-5. PubMed ID: 15307103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
    Melnyk A; Rodriguez A; Pugh WC; Cabannillas F
    Blood; 1997 Jun; 89(12):4514-20. PubMed ID: 9192775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis.
    Ohshima K; Karube K; Kawano R; Tsuchiya T; Suefuji H; Yamaguchi T; Suzumiya J; Kikuchii M
    Int J Oncol; 2004 Sep; 25(3):605-13. PubMed ID: 15289861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
    Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
    J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.
    Arrowsmith ER; Macon WR; Kinney MC; Stein RS; Goodman SA; Morgan DS; Flexner JM; Cousar JB; Jagasia MH; McCurley TL; Greer JP
    Leuk Lymphoma; 2003 Feb; 44(2):241-9. PubMed ID: 12688340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hodgkin's lymphoma in southeast Turkey: clinicopathologic features of 490 cases.
    Isikdogan A; Ayyildiz O; Buyukcelik A; Arslan A; Tiftik N; Buyukbayram H; Muftuoglu E
    Ann Hematol; 2004 May; 83(5):265-9. PubMed ID: 15060744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.
    Grierson HL; Wooldridge TN; Purtilo DT; Pierson J; Bast M; Wooldridge L; Armitage JO; Weisenburger DD
    Cancer Res; 1990 Aug; 50(16):4845-8. PubMed ID: 2379148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.